Copyright
©The Author(s) 2015.
World J Diabetes. Mar 15, 2015; 6(2): 345-351
Published online Mar 15, 2015. doi: 10.4239/wjd.v6.i2.345
Published online Mar 15, 2015. doi: 10.4239/wjd.v6.i2.345
Article | Age | HbA1c target | Population |
The 2014 ADA guidelines[4] | Any age | < 7% | Adult patients without serious comorbidities |
< 8% | Patients with a more complex status (see text) Age itself not a criteria | ||
The consensus report of the ADA and the | > 65 yr | < 7.5% | Healthy old patients |
American Geriatrics Society 2012[14] | < 8% | Patients with intermediate health status (multiple chronic illnesses or 2+ instrumental impairments or mild cognitive impairment) | |
< 8.5% | Patients with poor health status (end-stage chronic illnesses or moderate to severe cognitive impairment or 2+ ADL dependencies) | ||
The 2013 IDF guidelines[39] | > 70 yr | 7%-7.5% | Functionally independent old patients |
7%-8% | Functionally dependent old patients | ||
< 8.5% | Frail elderly or dementia | ||
Any HbA1c; just to avoid hypoglycemia | Patients at end-of-life |
- Citation: Twito O, Frankel M, Nabriski D. Impact of glucose level on morbidity and mortality in elderly with diabetes and pre-diabetes. World J Diabetes 2015; 6(2): 345-351
- URL: https://www.wjgnet.com/1948-9358/full/v6/i2/345.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i2.345